Ang Robert E

🇯🇧 Asian Eye Institute

2 articles in GJC

Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension.

Sarkisian Steven R, Ang Robert E, Lee Andy M, Berdahl John P, Heersink Sebastian B, Burden James H et al.

OphthalmologyFeb 202416 citationsRandomized Controlled Trial

Travoprost intraocular implants effectively lowered IOP in glaucoma/ocular hypertension patients, proving non-inferior to timolol over 3 months with a favorable safety profile, offering a sustained treatment option.

Full abstract PubMed

A Prospective Randomized Trial Comparing Hydrus and iStent Microinvasive Glaucoma Surgery Implants for Standalone Treatment of Open-Angle Glaucoma: The COMPARE Study.

Ahmed Iqbal Ike K, Fea Antonio, Au Leon, Ang Robert E, Harasymowycz Paul, Jampel Henry D et al.

OphthalmologyApr 20190 citationsRandomized Controlled Trial

This study compared standalone Hydrus vs. iStent MIGS for open-angle glaucoma. Hydrus showed higher surgical success and greater medication reduction, suggesting it may be a more effective option.

Full abstract PubMed

All 2 articles loaded

Global Search

Ang Robert E

Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension.

A Prospective Randomized Trial Comparing Hydrus and iStent Microinvasive Glaucoma Surgery Implants for Standalone Treatment of Open-Angle Glaucoma: The COMPARE Study.